Видео ютуба по тегу Teva Earnings

$TEVA Teva Pharmaceutical Q2 2025 Earnings Conference Call
$TEVA Teva Pharmaceutical Q2 2025 Earnings Conference Call
Teva Pharmaceutical Industries Limited TEVA Q3 2025 Earnings Call
Teva Pharmaceutical Industries Limited TEVA Q3 2025 Earnings Call
$TEVA Teva Pharmaceutical Q4 2024 Earnings Conference Call
$TEVA Teva Pharmaceutical Q4 2024 Earnings Conference Call
Teva Pharmaceutical Industries TEVA Q2 2025 Earnings Call
Teva Pharmaceutical Industries TEVA Q2 2025 Earnings Call
Deep Dive: Teva Pharmaceuticals Delivers 10 Consecutive Quarters of Revenue Growth (TEVA)
Deep Dive: Teva Pharmaceuticals Delivers 10 Consecutive Quarters of Revenue Growth (TEVA)
Teva Pharma shares up after positive results from migraine drug trial: Tirrell
Teva Pharma shares up after positive results from migraine drug trial: Tirrell
Teva Hits Highest Since 2018 as 3Q Revenue Beats Estimates
Teva Hits Highest Since 2018 as 3Q Revenue Beats Estimates
TEVA Q1 2025 Earnings: Innovative Drugs Power Growth, Margins Expand
TEVA Q1 2025 Earnings: Innovative Drugs Power Growth, Margins Expand
TEVA Update - Earnings, Debt and good news on Litigation!
TEVA Update - Earnings, Debt and good news on Litigation!
Teva CEO Calls 'Trough' Revenues Consequence of Patent Expirations
Teva CEO Calls 'Trough' Revenues Consequence of Patent Expirations
TEVA Teva Pharmaceutical Industries: $40 PT, Q4‑2026 Eylea Deal - 5 Price Predictions + Wednesday Pr
TEVA Teva Pharmaceutical Industries: $40 PT, Q4‑2026 Eylea Deal - 5 Price Predictions + Wednesday Pr
Teva Pharmaceutical (TLV: TEVA) - Q4 2024 Earnings Call
Teva Pharmaceutical (TLV: TEVA) - Q4 2024 Earnings Call
Teva CEO Richard Francis on Q2 earnings beat
Teva CEO Richard Francis on Q2 earnings beat
FDA approves Teva's generic EpiPen
FDA approves Teva's generic EpiPen
Watch CNBC's full interview with Teva CEO Richard Francis
Watch CNBC's full interview with Teva CEO Richard Francis
Teva 2023Q1 Earnings Call
Teva 2023Q1 Earnings Call
Teva Q2 2025 Earnings Call: AI-Powered Podcast
Teva Q2 2025 Earnings Call: AI-Powered Podcast
Teva Pharmacuetical Earnings Reaction: 11/15/16
Teva Pharmacuetical Earnings Reaction: 11/15/16
Teva Pharmaceutical Industries Ltd - People at Work
Teva Pharmaceutical Industries Ltd - People at Work
Teva (TEVA|$18.6B) - 2025 Q1 Earnings Analysis
Teva (TEVA|$18.6B) - 2025 Q1 Earnings Analysis
TEVA Stock | Teva Pharmaceuticals Q2 2021 Earnings Call
TEVA Stock | Teva Pharmaceuticals Q2 2021 Earnings Call